Schizophrenia is a severe and complex mental disorder that causes an enormous societal and financial burden. Following the identification of dopamine as a neurotransmitter and the invention of antipsychotic drugs, the dopamine hypothesis was formulated to suggest hyperdopaminergia as the cause of schizophrenia. Over time there have been modifications and improvements to the dopamine-based model of schizophrenia, as well as models that do not implicate dopamine dysregulation as a primary cause of the disease. It seems clear by now that disruption of dopamine homeostasis occurs in schizophrenia and likely plays a major contributory role to its symptoms. Three primary versions of the dopamine hypothesis of schizophrenia have been proposed. In this article, we review these hypotheses and subject their assumptions to a computational model of dopamine signaling. Based on this review and analysis, we propose slight revisions to the existing hypotheses. Although we are still at the beginning of a comprehensive modeling effort to capture relevant phenomena associated with schizophrenia, our preliminary models have already yielded intriguing results and identified the systems biological approach as a beneficial complement to clinical and experimental research and a powerful method for exploring human diseases like schizophrenia. It is hoped that the past, present and future models will support and guide refined experimentation and lead to a deeper understanding of schizophrenia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0030-1248317 | DOI Listing |
Nat Commun
January 2025
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Identifying cell types and brain regions critical for psychiatric disorders and brain traits is essential for targeted neurobiological research. By integrating genomic insights from genome-wide association studies with a comprehensive single-cell transcriptomic atlas of the adult human brain, we prioritized specific neuronal clusters significantly enriched for the SNP-heritabilities for schizophrenia, bipolar disorder, and major depressive disorder along with intelligence, education, and neuroticism. Extrapolation of cell-type results to brain regions reveals the whole-brain impact of schizophrenia genetic risk, with subregions in the hippocampus and amygdala exhibiting the most significant enrichment of SNP-heritability.
View Article and Find Full Text PDFNeuroscience
January 2025
School of Aerospace Engineering, Xi'an Jiaotong University, Xi'an, China; State Key Laboratory for Strength and Vibration of Mechanical Structures, Xi'an, China; National Demonstration Center for Experimental Mechanics Education, Xi'an Jiaotong University, Xi'an, China. Electronic address:
Schizophrenia (SCHZ), bipolar disorder (BD), and attention-deficit/hyperactivity disorder (ADHD) share clinical symptoms and risk genes, but the shared and distinct neural dynamic mechanisms remain inadequately understood. Degree is a fundamental and important graph measure in network neuroscience, and we here extended the degree to hierarchical levels based on eigenmodes and compared the resting-state brain networks of three disorders and healthy controls (HC). First, compared to HC, SCHZ and BD patients exhibited substantially overlapped abnormalities in brain networks, wherein BD patients displayed more significant alterations.
View Article and Find Full Text PDFJ Psychiatr Res
December 2024
Department of Psychiatry, Stellenbosch University, Cape Town, South Africa.
Despite research advances and progress in health care, schizophrenia remains a debilitating and costly disease. Onset occurs typically during youth and can lead to a relapsing and ultimately chronic course with persistent symptoms and functional impairment if not promptly and properly treated. Consequently, over time, schizophrenia causes substantial distress and disability for patients, their families and accrues to a collective burden to society.
View Article and Find Full Text PDFGen Hosp Psychiatry
December 2024
Geha Mental Health Center, Petach Tikva, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Background: Morbidity and mortality rates are notably higher among individuals with severe mental illnesses (SMI). People with SMI often have lower access to healthcare services, and the medical care they receive is known to be suboptimal. Consequently, treatment in an acute care setting rather than a community setting is more common.
View Article and Find Full Text PDFAustralas Psychiatry
January 2025
National Centre for Epidemiology and Population Health, School of Medicine and Psychology, The Australian National University, Acton, ACT, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!